These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 2080982)
21. Bioerodible polymers for ocular drug delivery. Deshpande AA; Heller J; Gurny R Crit Rev Ther Drug Carrier Syst; 1998; 15(4):381-420. PubMed ID: 9736417 [TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory drug incorporation into polymeric nano-hybrids for local controlled release. Sammartino G; Marenzi G; Tammaro L; Bolognese A; Calignano A; Costantino U; Califano L; Mastrangelo F; Tetè S; Vittoria V Int J Immunopathol Pharmacol; 2005; 18(3 Suppl):55-62. PubMed ID: 16848988 [TBL] [Abstract][Full Text] [Related]
23. [Matrices for controlled liberation by swelling of polymers. II: Preparation of drug delivery systems and analysis of liberation kinetics]. Gander B; Gurny R; Doelker E Pharm Acta Helv; 1986; 61(7):178-84. PubMed ID: 3737618 [No Abstract] [Full Text] [Related]
24. Polymer blends for controlled release coatings. Siepmann F; Siepmann J; Walther M; MacRae RJ; Bodmeier R J Control Release; 2008 Jan; 125(1):1-15. PubMed ID: 18022722 [TBL] [Abstract][Full Text] [Related]
25. Polymeric prodrugs. Azori M Crit Rev Ther Drug Carrier Syst; 1987; 4(1):39-65. PubMed ID: 3315236 [TBL] [Abstract][Full Text] [Related]
26. [Controlled-release drugs: administration routes and formulations]. Nicoli S; Colombo P Ann Pharm Fr; 2001 Jul; 59(4):227-31. PubMed ID: 11468576 [TBL] [Abstract][Full Text] [Related]
27. [Thermosensitive polymers in drug form technology. I. Classification and characteristics]. Pluta J; Karolewicz B Polim Med; 2008; 38(1):3-14. PubMed ID: 18661702 [TBL] [Abstract][Full Text] [Related]
28. Solvent evaporation processes for the production of controlled release biodegradable microsphere formulations for therapeutics and vaccines. Cleland JL Biotechnol Prog; 1998; 14(1):102-7. PubMed ID: 9496674 [TBL] [Abstract][Full Text] [Related]
29. Biocompatibility of polymeric delivery systems for macromolecules. Langer R; Brem H; Tapper D J Biomed Mater Res; 1981 Mar; 15(2):267-77. PubMed ID: 7348718 [TBL] [Abstract][Full Text] [Related]
30. Pharmaceutical design and development of a Sinemet controlled-release formulation. Dempski RE; Scholtz EC; Oberholtzer ER; Yeh KC Neurology; 1989 Nov; 39(11 Suppl 2):20-4. PubMed ID: 2685648 [TBL] [Abstract][Full Text] [Related]
32. Materials and biological aspects of synthetic polymers in controlled drug release systems: problems and challenges. Bruck SD; Mueller EP Crit Rev Ther Drug Carrier Syst; 1988; 5(3):171-87. PubMed ID: 3060266 [TBL] [Abstract][Full Text] [Related]
33. Oral drug delivery systems comprising altered geometric configurations for controlled drug delivery. Moodley K; Pillay V; Choonara YE; du Toit LC; Ndesendo VM; Kumar P; Cooppan S; Bawa P Int J Mol Sci; 2012; 13(1):18-43. PubMed ID: 22312236 [TBL] [Abstract][Full Text] [Related]
34. POLYMERIC PHARMACEUTICAL COATING MATERIALS. I. PREPARATION AND PROPERTIES. LAPPAS LC; MCKEEHAN W J Pharm Sci; 1965 Feb; 54():176-81. PubMed ID: 14293799 [No Abstract] [Full Text] [Related]